Archives of Clinical Infectious Diseases

Published by: Kowsar

Cloning and Expression of HP0242 Hypothetical Gene as a DNA Vaccine Candidate for Helicobacter pylori and Study of Its Immunoreactivity

Zahra Bagheri 1 , Abdolmajid Ghasemian 2 , 3 , Seyyed Khalil Shokouhi Mostafavi 4 and Abbas Doosti 1 , *
Authors Information
1 Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, IR Iran
2 Department of Microbiology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, IR Iran
3 Department of Epidemiology, Pasteur Institute of Iran, Tehran, IR Iran
4 Department of Microbiology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2018, 13 (1); e57487
  • Published Online: January 23, 2018
  • Article Type: Research Article
  • Received: September 25, 2016
  • Revised: July 3, 2017
  • Accepted: September 22, 2017
  • DOI: 10.5812/archcid.57487

To Cite: Bagheri Z, Ghasemian A, Shokouhi Mostafavi S K, Doosti A. Cloning and Expression of HP0242 Hypothetical Gene as a DNA Vaccine Candidate for Helicobacter pylori and Study of Its Immunoreactivity, Arch Clin Infect Dis. 2018 ; 13(1):e57487. doi: 10.5812/archcid.57487.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Stewart AJ, Devlin PM. The history of the smallpox vaccine. J Infect. 2006;52(5):329-34. doi: 10.1016/j.jinf.2005.07.021. [PubMed: 16176833].
  • 2. Salehi M, Ghasemian A, Shokouhi Mostafavi SK, Najafi S, Rajabi Vardanjani H. Sero-prevalence of Helicobacter pylori Infection in Neyshabur, Iran, During 2010-2015. Iran J Pathol. 2017;12(2):183-8.
  • 3. Todoroki I, Joh T, Watanabe K, Miyashita M, Seno K, Nomura T, et al. Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice. Biochem Biophys Res Commun. 2000;277(1):159-63. doi: 10.1006/bbrc.2000.3632. [PubMed: 11027657].
  • 4. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007;133(1):288-308. doi: 10.1053/j.gastro.2007.05.008. [PubMed: 17631150].
  • 5. Flingai S, Czerwonko M, Goodman J, Kudchodkar SB, Muthumani K, Weiner DB. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Front Immunol. 2013;4:354. doi: 10.3389/fimmu.2013.00354. [PubMed: 24204366].
  • 6. Kennedy RB, Ovsyannikova IG, Lambert ND, Haralambieva IH, Poland GA. The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines. 2014;13(5):657-69. doi: 10.1586/14760584.2014.905744. [PubMed: 24702429].
  • 7. Tsai JY, Chen BT, Cheng HC, Chen HY, Hsaio NW, Lyu PC, et al. Crystal structure of HP0242, a hypothetical protein from Helicobacter pylori with a novel fold. Proteins. 2006;62(4):1138-43. doi: 10.1002/prot.20864. [PubMed: 16395670].
  • 8. Wang LW, Shih P, Liu YN, Hsu BD, Lyu PC, Hsu STD. Multiparametric Characterization of the Three-state Folding Equilibrium of a Psudo-knotted Protein from H. pylori. 2014.
  • 9. Sapmaz F, Basyigit S, Kalkan IH, Kisa U, Kavak EE, Guliter S. The impact of Helicobacter pylori eradication on serum hepcidin-25 level and iron parameters in patients with iron deficiency anemia. Wien Klin Wochenschr. 2016;128(9-10):335-40. doi: 10.1007/s00508-016-0961-5. [PubMed: 26932797].
  • 10. Choe YH. Extraintestinal Manifestations of H. pylori Infection: H. pylori-Associated Iron-Deficiency Anemia. Springer; 2016.
  • 11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold spring harbor laboratory press; 1989.
  • 12. Zimmerman SA, Tomb JF, Ferry JG. Characterization of CamH from Methanosarcina thermophila, founding member of a subclass of the {gamma} class of carbonic anhydrases. J Bacteriol. 2010;192(5):1353-60. doi: 10.1128/JB.01164-09. [PubMed: 20023030].
  • 13. Legendre N. Purification of Proteins and Peptides by SDS-PAGE--A Practical Guide to Protein and Peptide Purification for Microsequencing (Edited by Matsudaira PT). Academic Press, New York; 1989.
  • 14. Chen J, Li N, She F. Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice. Vaccine. 2014;32(46):6054-60. doi: 10.1016/j.vaccine.2014.09.014. [PubMed: 25236588].
  • 15. Chen J, Lin L, Li N, She F. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids. Microbiol Immunol. 2012;56(2):85-92. doi: 10.1111/j.1348-0421.2011.00409.x. [PubMed: 22150716].
  • 16. Soleimani N, Mohabati Mobarez A, Farhangi B. Cloning, expression and purification flagellar sheath adhesion of Helicobacter pylori in Escherichia coli host as a vaccination target. Clin Exp Vaccine Res. 2016;5(1):19-25. doi: 10.7774/cevr.2016.5.1.19. [PubMed: 26866020].
  • 17. Wang KX, Wang XF. Cloning and sequencing of cagA gene fragment of Helicobacter pylori with coccoid form. World J Gastroenterol. 2004;10(23):3511-3. [PubMed: 15526375].
  • 18. Xu C, Li ZS, Du YQ, Tu ZX, Gong YF, Jin J, et al. Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA. World J Gastroenterol. 2005;11(1):114-7. [PubMed: 15609408].
  • 19. Zhang XJ, Feng SY, Li ZT, Feng YM. Expression of Helicobacter pylori hspA gene in Lactococcus lactis NICE system and experimental study on its immunoreactivity. Gastroenterol Res Pract. 2015;2015.
  • 20. Zhang HX, Qiu YY, Zhao YH, Liu XT, Liu M, Yu AL. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Mol Cell Probes. 2014;28(1):25-30. doi: 10.1016/j.mcp.2013.08.003. [PubMed: 24036137].
  • 21. Yang J, Dai LX, Pan X, Wang H, Li B, Zhu J, et al. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB. Pathog Dis. 2015;73(5). doi: 10.1093/femspd/ftv026. [PubMed: 25846576].
  • 22. Mirzaei N, Poursina F, Moghim S, Rashidi N, Ghasemian Safaei H. The study of H. pylori putative candidate factors for single- and multi-component vaccine development. Crit Rev Microbiol. 2017;43(5):631-50. doi: 10.1080/1040841x.2017.1291578.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments